Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 11/20 | 0.72 |
| ▸ | NPC1 | O15118 | 10/20 | 0.72 |
| ▸ | GAA | P10253 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 13/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.69 |
| ▸ | HPGD | P15428 | 6/20 | 0.69 |
| ▸ | TP53 | P04637 | 4/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.69 |
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 2/20 | 0.69 |
| ▸ | GFER | P55789 | 1/20 | 0.69 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.66 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 3/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20445410 | 0.91 | KDM4E (0.68) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL3929438 | 0.91 | KDM4E (0.60) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL20445296 | 0.91 | NPC1 (0.60) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL28256337 | 0.91 | NPC1 (0.66) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL29386825 | 0.90 | NPC1 (0.88) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL2178266 | 0.90 | NPC1 (0.88) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL24295036 | 0.88 | NPC1 (0.84) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL3928063 | 0.88 | RAB9A (0.57) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL3926454 | 0.88 | CHEK2 (0.64) | RAB9ANPC1GAAKDM4EALDH1A1 | |
| SCHEMBL5677793 | 0.88 | CHEK2 (0.62) | RAB9ANPC1GAAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115433929-B | Organic solderability copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-115433929-A | Organic weldable copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| US-7470827-B2 | Composition for the vapor phase dehydrohalogenation of 1,1,2-trihaloethane to 1,1-dihaloethylene and methods for preparing and using such composition | PPG INDUSTRIES OHIO, INC. (US) | 2008-12-30 | — | — | US | claimed |
| US-20080242902-A1 | Composition For the Vapor Phase Dehydrohalogenation of 1,1,2-Trihaloethane To 1,1-Dihaloethylene and Methods For Preparing and Using Such Composition | PPG INDUSTRIES OHIO, INC (US) | 2008-10-02 | — | — | US | claimed |
| EP-0251760-B1 | Rubber composition | BRIDGESTONE CORP (JP) | 1994-01-26 | — | — | EP | claimed |
| US-5140055-A | Improved high speed grip performance | BRIDGESTONE CORPORATION (JP) | 1992-08-18 | — | — | US | claimed |
| US-12403128-B2 | Compositions and methods for blocking sodium channels | Univerity of Virginia Patent Foundation (US) | 2025-09-02 | — | — | US | disclosed |
| US-12195432-B2 | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-01-14 | — | — | US | disclosed |
| CN-118440272-A | Thiophene-triazinyl flexible D-A covalent organic framework material, preparation method and application | 天津大学 | 2024-08-06 | — | — | CN | disclosed |
| WO-2024137505-A2 | METHOD OF IMPROVING CELL FITNESS IN AN EX-VIVO CELL POPULATION | TRANQUIS THERAPEUTICS, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| CN-117603421-A | Perylene bisimide covalent organic framework material and preparation method and application thereof | 天津大学浙江研究院(绍兴) | 2024-02-27 | — | — | CN | disclosed |
| CN-114989094-B | Method for synthesizing benzimidazole derivative by visible light catalysis | 云南民族大学 | 2023-09-29 | — | — | CN | disclosed |
| CN-116635028-A | Modulators of c-MYC mRNA translation and their use in the treatment of cancer | 艾尼莫生物科技公司 | 2023-08-22 | — | — | CN | disclosed |
| EP-0871442-A1 | BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1997025041-A1 | BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-07-17 | — | — | WO | disclosed |
| EP-0251760-B1 | Rubber composition | BRIDGESTONE CORP (JP) | 1994-01-26 | — | — | EP | disclosed |
| US-5140055-A | Improved high speed grip performance | BRIDGESTONE CORPORATION (JP) | 1992-08-18 | — | — | US | disclosed |
| EP-0479161-A1 | Synthesis of heterocyclic compounds | EASTMAN CHEMICAL COMPANY (US) | 1992-04-08 | — | — | EP | disclosed |
| EP-0251760-A2 | Rubber composition | Bridgestone Corporation (JP) | 1988-01-07 | — | — | EP | disclosed |
| US-3953600-A | HYPOLIPIDEMIC AGENTS | SANDOZ, INC. (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12403128-B2 | Compositions and methods for blocking sodium channels | SCN3A, SCN1B, SCN2B | RAB9A 2068/4885NPC1 483/4885GAA 1051/4885 |
| US-12195432-B2 | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | PPARG, PPARA, PPARD | RAB9A 2214/4885NPC1 989/4885GAA 382/4885 |
| US-20080242902-A1 | Composition For the Vapor Phase Dehydrohalogenation of 1,1,2-Trihaloethane To 1,1-Dihaloethylene and Methods For Preparing and Using Such Composition | CYP2E1, CYP1A1, HDHD5 | RAB9A 3877/4885NPC1 2698/4885GAA 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.